Alzheimers Res Ther. 2010 Jun 8;2(3):15.

Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?

Source

Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, CL 291, Indianapolis, IN 46202, USA. mfarlow@iupui.edu.

Abstract

Should the apolipoprotein E (ApoE) genotype be a covariate for clinical trials in Alzheimer disease (AD)? ApoE is a transport protein for lipids, amyloid-beta proteins, and the different phenotypes differentially affect amyloid-beta deposition, neurofibrillary tangle formation, and microglial activation. The ApoE genotype has not affected efficacy in short symptomatic AD trials. ApoE4 has been associated with greater efficacy in at least two mild cognitive impairment studies. Vasogenic edema was more frequent in ApoE4 AD patients treated with a monoclonal antibody to amyloid beta. Since there is evidence that the ApoE genotype may differentially affect disease mechanisms, efficacy, and adverse effects in both AD and mild cognitive impairment trials, the ApoE genotype should be included as a covariate in future studies.

PMID:: 20537201; [PubMed]
PMCID: PMC2919695

Free PMC Article

Publication Types

Editorial

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. [Arch Neurol. 2000]
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ. Arch Neurol. 2000 Jun; 57(6):869-74.
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. [Biochem Biophys Res Commun. 1995]
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
Richey PL, Siedlak SL, Smith MA, Perry G. Biochem Biophys Res Commun. 1995 Mar 17; 208(2):657-63.
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. [Arch Neurol. 2005]
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R. Arch Neurol. 2005 Jun; 62(6):975-80.
Review Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease. [J Mol Neurosci. 2004]
Review Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease.
Refolo LM, Fillit HM. J Mol Neurosci. 2004; 23(3):151-5.
Review ApoE genotype accounts for the vast majority of AD risk and AD pathology. [Neurobiol Aging. 2004]
Review ApoE genotype accounts for the vast majority of AD risk and AD pathology.
Raber J, Huang Y, Ashford JW. Neurobiol Aging. 2004 May-Jun; 25(5):641-50.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease...
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
Alzheimers Res Ther. 2010 Jun 8 ;2(3):15.

PubMed
Cell cycle molecules and vertebrate neuron death: E2F at the hub.
Cell cycle molecules and vertebrate neuron death: E2F at the hub.
Cell Death Differ. 2004 Jan ;11(1):49-60.

PubMed
Genome-wide association study identifies variants at CLU and PICALM associated w...
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Nat Genet. 2009 Oct ;41(10):1088-93. Epub 2009 Sep 6 .

PubMed
The role of animal models in advancing amyloid-beta immunotherapy to the clinic.
The role of animal models in advancing amyloid-beta immunotherapy to the clinic.
Alzheimers Res Ther. 2010 Jul 29 ;2(4):22.

PubMed
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in th...
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
Nature. 1999 Jul 8 ;400(6740):173-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?

Source

Abstract

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information